Gender identity, overconfidence, and risk attitudes
Journal of Consumer Psychology · 2026-07 · 36 (3) · 369-379
DOI: 10.1002/jcpy.70022 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Consumer Psychology, online erschienen am 16.06.2026. Verfasst von Edward R. Lawrence und 1 weiteren Autor:innen. Die Arbeit nennt 52 Literaturangaben.
Abstract (Originalsprache)
We explore the relationship between gender identity, overconfidence, and investment risk‐taking behaviors. We quantify overconfidence as a discrepancy between an individual's perceived and actual financial knowledge, and our empirical analysis reveals significant differences in overconfidence levels across gender identities. Consumers who identify as nonbinary exhibit significantly lower levels of financial overconfidence compared to individuals identifying as either male or female. The lower levels of overconfidence are attributed to a more modest self‐assessment of financial knowledge rather than a difference in actual knowledge. Higher overconfidence is linked with a greater willingness to take on financial risks. Nonbinary individuals exhibit a considerably lower inclination to take risks in their investment decisions. While nonbinary individuals are more likely to experience mental health challenges, these do not explain the reduced levels of overconfidence and risk‐taking. Moreover, the nonbinary pattern is not a generic minority effect.
Zitieren
APA
Lawrence, E. R., & Wick, B. (2026). Gender identity, overconfidence, and risk attitudes. Journal of Consumer Psychology, 36(3), 369-379. https://doi.org/10.1002/jcpy.70022
Vancouver
Lawrence ER, Wick B. Gender identity, overconfidence, and risk attitudes. Journal of Consumer Psychology. 2026;36(3):369-379. doi:10.1002/jcpy.70022
BibTeX
@article{Lawrence2026,
author = {Lawrence, Edward R. and Wick, Benedikt},
title = {Gender identity, overconfidence, and risk attitudes},
journal = {Journal of Consumer Psychology},
year = {2026},
volume = {36},
number = {3},
pages = {369--379},
doi = {10.1002/jcpy.70022}
}
EUVIMED